Home / Biosimilars
Biosimilars
News
Advances for Formycon and Alteogen’s eye disease biosimilar candidates
posted 16/04/2021
In March 2021, Formycon confirmed the resubmission strategy for their Lucentis® (ranibizumab) biosimilar candidate (FYB2010)... 
FDA accepts application for adalimumab biosimilar CHS-1420
posted 16/04/2021
US-based Coherus BioSciences (Coherus) announced on 17 February 2021 that the US Food and Drug Administration (FDA) had accep... 
Australian and Indian approval for teriparatide products
posted 16/04/2021
Australia’s drug regulatory agency, the Therapeutic Goods Administration (TGA), has approved a teriparatide biosimilar and th... 
Argentina approves bevacizumab similar biological medicine Zutrab
posted 16/04/2021
The Argentina-based Richmond Laboratory (Laboratorios Richmond) announced on 19 March 2021 that it had gained approval from A... 
EC approval for insulin aspart biosimilar Kixelle
posted 16/04/2021
The European Commission (EC) has granted marketing authorization for the insulin aspart biosimilar Kixelle (MYL 1601D), devel... |
Research
Characteristics associated with biosimilar use in Medicare recipients
posted 16/04/2021
What patient, physician and practice characteristics are associated with biosimilar usage for the biologicals filgrastim and... 
Biosimilars in the treatment of psoriasis
posted 16/04/2021
A recent paper by Spanish dermatologists reviews the principles of biosimilarity and equivalence trials that have led to the... 
Adalimumab biosimilar FKB327 causes less pain than originator
posted 12/04/2021
Fujifilm Kyowa Kirin Biologics’ adalimumab biosimilar FKB327 has been found to cause less injection-site pain compared to the... 
Biosimilars regulation, clinical trials, approval and adverse events in Malaysia
posted 12/04/2021
Compared to chemical drugs, biologicals are more expensive because of their complicated manufacturing processes. Patients oft... 
Etanercept biosimilar injection pen, YLB113, convenient and easy to use
posted 09/04/2021
A study of an injection pen formulation of the etanercept biosimilar YLB113, which is manufactured by the Japanese firm YL Bi... |
General
British Columbia adds adalimumab to biosimilar switching programme
posted 16/04/2021
British Columbia (BC), the first province in Canada to switch patients to biosimilar drugs, has added adalimumab to its switc...
Biosimilars of ustekinumab
posted 12/04/2021
Ustekinumab is a humanized monoclonal antibody that interferes with the triggering of the body’s inflammatory response throug...
Biosimilars of aflibercept
posted 09/04/2021
Aflibercept is a vascular endothelial growth factor (VEGF) inhibitor. It is indicated for the treatment of neovascular (wet)... 
Copy biologicals approved in China
posted 09/04/2021
Last update: 2 April 2021In China, the regulatory body for the approval of medicines, including biologicals, is the National... 
Biosimilars approved in South Korea
posted 02/04/2021
Last update: 26 March 2021In South Korea, the regulatory body for the approval of medicines, including biologicals and b... |
Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!
Biosimilars
General
News
- Advances for Formycon and Alteogen’s eye disease biosimilar candidates
- FDA accepts application for adalimumab biosimilar CHS-1420
Research
Generics News Research General
- US$1.2 FDA contract for generic drug computatio...Generics/General | Posted 16/04/2021
- Dispensing branded drugs costs Medicare over a...Generics/Research | Posted 09/04/2021
- Technological approaches to drug repurposing fo...Generics/Research | Posted 02/04/2021
- EMA recommends approval of abiraterone and thio...Generics/News | Posted 02/04/2021
Biosimilars News Research General
- Characteristics associated with biosimilar use...Biosimilars/Research | Posted 16/04/2021
- British Columbia adds adalimumab to biosimilar...Biosimilars/General | Posted 16/04/2021
- Biosimilars in the treatment of psoriasisBiosimilars/Research | Posted 16/04/2021
- Advances for Formycon and Alteogen’s eye diseas...Biosimilars/News | Posted 16/04/2021